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Acinetobacter baumannii is widely recognized as an important pathogen associated with noso-
comial  infections. The treatment of these infections is often difﬁcult due to the acquisition
of  resistance genes. A. baumannii presents a high genetic plasticity which allows the accu-
mulation of these resistance determinants leading to multidrug resistance. It is highlighted
the  importance of the horizontal transfer of resistance genes, through mobile genetic ele-
ments and its relationship with increased incidence of multidrug resistant A. baumannii in
hospitals. Considering that resistance to carbapenems is very important from the clinical
and  epidemiological point of view, the aim of this article is to present an overview of the
current knowledge about genetic elements related to carbapenem resistance in A. baumannii
such  as integrons, transposons, resistance islands and insertion sequences.obile genetic elements
arbapenem resistance
©  2016 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda. This is
an  open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
nary tract infections and meningitis. This species is naturally
highly resistant to a number of antimicrobials commonlyntroduction
he Acinetobacter baumannii-calcoaceticus (Abc) complex has
merged as an important nosocomial pathogen. Among the
embers of this complex, A. baumannii,  A. pittii, and A. noso-
omialis are the three most common Acinetobacter species
solated in clinical settings.1 A. baumannii has been extensively
tudied due to its association with infections of high mortality
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causative agents of nosocomial infections.2
A. baumannii is considered an important nosocomial
pathogen, causing a wide range of infections, including
ventilator-associated pneumonia, bloodstream infections, uri- Farroupilha, Porto Alegre CEP 90050-170, Brazil.
used in the clinical practice, such as ﬁrst and second genera-
tion cephalosporins, aminopenicillins, and chloramphenicol.
lsevier Editora Ltda. This is an open access article under the CC
.
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ferase gene aac3, and the aminoglycoside adenyltransferases
aadA1/DA1/B; the cotrimoxazole resistance-associated dfrI;786  b r a z i l i a n j o u r n a l o f m
A. baumannii contains an intrinsic AmpC -lactamase (blaADC)
and OXA-51 serine-type oxacilinase (blaOXA-51), which con-
tribute to the natural resistance to -lactams.3 Moreover, this
organism presents a great capacity to acquire new resistance
mechanisms, including those responsible for carbapenem
resistance.4
Carbapenem resistance in A. baumannii involves mainly
the carbapenem-hydrolysing class D -lactamases (CHDLs –
Ambler class D) and less frequently, the metallo--lactamases
(MBLs – Ambler class B). Carbapenem resistance may also be
caused by other mechanisms such as, production of other car-
bapenemases, porin modiﬁcation or loss, or by modiﬁcation of
the penicillin-binding proteins.1,5
Several acquired class D OXA-type -lactamases have been
identiﬁed as a source of carbapenem resistance in A. bau-
mannii. Five main groups of CHDLs have been described in
A. baumannii,  corresponding to OXA-23-like, OXA-24/40-like,
OXA-58-like, OXA-143-like and OXA-235-like enzymes.6 OXA-
23-like enzymes are the most widespread in A. baumannii
worldwide and have been identiﬁed in all continents.6
In Brazil, OXA-23-like-producing A. baumannii is dissemi-
nated in many  states and it is responsible for high endemic
levels of multidrug-resistance.7,8 The blaOXA-143 gene has thus
far been detected only in A. baumannii isolates from Brazil and
is the second most frequent CHDL encoding gene.9–11
The blaOXA-143 gene is frequently found in the Southeast
region of Brazil, especially in the state of São Paulo. It is
important to note that two new variants of this gene were
recently described. The variants blaOXA-235 and blaOXA-231 were
described in Minas Gerais and Paraná states, respectively.12,13
This data demonstrates the detection of these new variants
of blaOXA-143 in Brazil is a cause of great concern and shows
the potential of these new CHDLs to spread to other Brazilian
regions.
Although blaOXA-24/40-like gene is disseminated in A. bau-
mannii in Europe, in Brazil, this gene is still rare, with only
a very few reports of a blaOXA-72 (blaOXA-24/40-like variant) in São
Paulo,9 Recife,14 Porto Alegre and Curitiba.
Despite MBLs are less commonly identiﬁed in A. baumannii
than the OXA-type carbapenemases, their hydrolytic activi-
ties to carbapenems are signiﬁcantly more  potent. Four MBLs
have been identiﬁed in A. baumannii:  IMP,  VIM, SIM and, more
recently, NDM.15 It is important to note that MBL genes,
such as NDM and IMP-1, have been described in Acinetobac-
ter non-baumannii species, which demonstrates the capacity of
these resistance genes to spread among different Acinetobacter
species.16,17
Most of Ambler class A ESBLs possess activity against peni-
cillins and broad-spectrum cephalosporins. However, speciﬁc
GES variants have been shown to possess the ability to com-
promise the efﬁcacy of carbapenems. Among A. baumannii,  the
variants GES-11 and GES-14 possess speciﬁc residues enlarg-
ing their hydrolysis spectrum (Table 1).18,19
The elevated genetic plasticity presented by A. baumannii
has allowed the accumulation of many  resistance determi-
nants, which contributed to the high incidence of A. baumannii
multirresistant to antibiotics. In this review, we present and
discuss the characteristics of the different mobile genetic ele-
ments involved in the transfer of resistance determinants in
A. baumannii. b i o l o g y 4 7 (2 0 1 6) 785–792
AbaR-type  genomic  resistance  islands
Genomic islands containing resistance markers are referred
to as resistance islands. Resistance islands have been
described mainly in Proteobacteria, including Shigella ﬂexneri,
Salmonella enterica, Vibrio cholerae, Staphylococcus aureus,  and
more  recently, in A. baumannii.20,21 A. baumannii isolates har-
bor large clusters of horizontally transferred genes conferring
resistance to multiple antibiotics and heavy metals, which are
integrated at a speciﬁc site in a particular ATPase gene.22
Fournier et al. described for the ﬁrst time the A. baumannii
Resistant Island (AbaR). AbaR is deﬁned as a region which has
transposed into a speciﬁc position in the chromosome, creat-
ing a 5 bp duplication site (ACCGC).21 The backbone of AbaR is
comprised of ﬁve open reading frames (ORFs) – orf1, tniA, tniB,
orf2, orf3 – which constitute the transposition module, and two
other genes encoding to the universal stress protein (uspA) and
a sulfate permease (sul).21–23
Several AbaR have already been described containing a
variety of resistance genes, including the blaOXA-23-like, which
confers resistance to carbapenems.24 These resistance islands
have been described in A. baumannii epidemic strains belong-
ing to the important global clones, European Clone I (EC I) and
European Clone II (EC II), known for their increased capacity
to spread worldwide.22
Several other genomic resistance islands have been fully
characterized in A. baumannii.  The majority were found in
strains of EC I, such as, AbaR1, AbaR3, AbaR5, AbaR6, AbaR7,
AbaR8, AbaR9, and AbaR10. These AbaRs share a structure
represented by a 16.3 kb backbone transposon (Tn6019) inter-
rupted by a large compound transposon that contains a
variable-resistance region bounded by directly oriented copies
of Tn6018. Exceptions are AbaR6 and AbaR7, each with a large
deleted region.25 Much less is known about AbaRs in EC II.
The resistance islands harbored by this clone are integrated
at the same site of the ATPase gene as is known for AbaRs in
EC I.25
AbaR1 is the largest resistance island described to date.
This island contains 86 kb and was originally described in the
epidemic A. baumannii strain AYE belonging to ECI. This strain
was responsible for outbreaks in France during 2004.21 A. bau-
mannii AYE strain revealed the presence of a large gene cluster,
containing many  resistance determinants, inserted into the
chromosome.21
Of the 45 resistance genes described in AbaR1 resistance
island, 25 were associated with resistance to several classes of
antibiotics. These include genes that had not been previously
described in Acinetobacter species such as strA, strB, aphA1,
and aac69 (encoding resistance to aminoglycosides); putative
tetracycline-resistance genes tetA (tetracycline efﬂux pump)
and tetR (repressor protein); dfrX (resistance to cotrimoxazole);
and the chloramphenicol-resistance gene cmlA (chloram-
phenicol efﬂux pump). Moreover, Fournier et al. (2006)
described the presence of genes in AbaR1 that encode VEB-1
and OXA-10 -lactamases, the aminoglycoside acetyltrans-cmlA5 and one copy of the chloramphenicol acetyl-transferase
cat; the rifampin ADP-ribosyltransferase gene arr-2; and ﬁve
b r a z i l i a n j o u r n a l o f m i c r o b i o l o g y 4 7 (2 0 1 6) 785–792 787
Table 1 – Characterization of the main mobile genetic elements associated with resistance in Acinetobacter baumannii.
Mobile genetic
element
Resistance genes associated Resistance proﬁle Geographic region Reference
ISAba1 blaOXA-23
blaOXA-51
blaOXA-58
blaAmpC
-Lactams
including
carbapenems
Worldwide
disseminated
Villalón  et al., 2013
Mugnier et al., 2010
Mugnier et al., 2009
ISAba2 blaOXA-58
blaAmpC
Carbapenems
Cephalosporins
France
Italy
Spain
Villalón  et al., 2013
Fernández Cuenca et al., 2012
Marqué et al., 2005
ISAba3 blaOXA-58 Carbapenems China
Italy
Taiwan
Lebanon
Villalón et al., 2013
Donnarumma et al., 2010
Zarrilli et al., 2008
Fu et al., 2014
ISAba4 blaOXA-23 Carbapenems France
Belgium
Bogaerts et al., 2008
Corvec et al., 2007
ISAba10 blaOXA-23 Carbapenems Korea Lee et al., 2011
ISAba125 blaNDM-1
blaNDM-2
blaAmpC
aphA6
Carbapenems
Cephalosporins
Aminoglycosides
India
Switzerland
Greece
Australia
Bonnin  et al., 2012a
Kaase et al., 2011
Mishra et al., 2013
Hamidian et al., 2012
IS18 blaOXA-58 Carbapenems Lebanon
Turkey
Villalón et al., 2013
Zarrilli et al., 2008
Marqué et al., 2005
Tn2006 blaOXA-23 Carbapenems Spain
Tahiti
France
Turkey
Vietnam
Romania
Lybia
Australia
Mugnier et al., 2010
Corvec et al., 2007
Tn2007 blaOXA-23 Carbapenems France
Algeria
Corvec et al., 2007
Tn2008 blaOXA-23 Carbapenems United Arab
Emirates
Bahrain
Mugnier et al., 2010
Int1 blaGES-11
blaGES-14
dfrA1
sat2
aadA1
orfX
ybfA
ybfB
-Lactams
including
carbapenems
Aminoglycosides
Europe
(widespread)
Korea
Iran
Brazil
Bonnin  et al., 2011
Nemec et al., 2004
Lee et al., 2005
Japoni-Nejad et al., 2013
Mendes et al., 2007
Int2 dfrA1
sat2
aadA1
orfX
ybfA
Aminoglycosides Argentina
Chile
Brazil
Pagano et al., 2012
Ramirez et al., 2012
Fonseca et al., 2011
c
d
A
a
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I
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n
lybfB
ybgA
opies of the sulfonamide-resistance gene sulI encoding dihy-
ropteroate synthetase, a component of class 1 integrons.21,26
AbaR2 was described in the epidemic, multidrug-resistant
. baumannii strain named ACICU.27 This strain belongs to ECII
nd carries the plasmid-mediated blaOXA-58. A. baumannii AYE
nd ACICU belong to different clonal groups (European clones
 and II, respectively), however, the presence of related resis-
ance islands in both lineages suggests that AbaR1 and AbaR2
erived from an island acquired by a common A. bauman-
ii ancestor before their divergence into two different clonal
ineages.21,27The genomic resistance island variant AbaR3 appears to
be an ancestral of several AbaR variants which have arisen
from AbaR3 by loss of segments of different lengths that
include one or more  of the antibiotic resistance genes.28
AbaR3 contains eight genes associated with antibiotic resis-
tance. Unique sequences in AbaR3 include a blaTEM gene that
is associated with a Tn3 transposon and a small cluster of
genes, including two that encode to a DNA topoisomerase
and a single-strand binding protein that are similar to pro-
teins from a broad-host-range plasmid.29 In addition, it is
noteworthy that the presence of genes for a plasmid-derived
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DNA topoisomerase may contribute to the resistance island
mobility.
Transposable  elements
Transposable elements have the ability to move within the
bacterial genome, being able to translocate themselves from
one site of the genome to other sites. These transpositions
are considered one of the major causes of bacterial DNA
rearrangements, which in turn can cause changes in gene
expression.30 In A. baumannii,  transposable elements, such
as transposons and insertion sequences have been responsi-
ble for the expression and spread of antimicrobial resistance
mechanisms.1
Insertion  sequences
Bacterial insertion sequences (IS) are the least complex type
of transposable elements; they rarely exceed 2 kb in size and
may be as small as 0.5 kb. These elements possess an impor-
tant role in the spread of resistance genes since the presence
of two copies of the same IS ﬂanking a resistance gene form
a complex structure called composite transposon. Composite
transposons are able to mobilize a variety of resistance genes,
contributing to antimicrobial resistance dissemination.31
Besides their transposition role, some IS have been shown
to activate or to increase the expression of neighbor genes.
This capacity may be due to the presence of promoter regions
in the insertion sequence or by the formation of new promo-
ters after the insertion event.31
Some IS elements have an important role in A. bauman-
nii antimicrobial resistance. ISAba1, ISAba2, ISAba3, ISAba4
and IS18 are commonly associated with the expression of
carbapenemases genes in A. baumannii (Table 1).32 Villalón
et al. (2013) investigated the presence of these IS elements in
59 multidrug-resistant A. baumannii isolates and observed a
prevalence of 93.2%, 25.4%, 20.3% and 5.1% for ISAba1, ISAba2,
ISAba3 and IS18,  respectively. ISAba4 was not detected in any
of the isolates in this study.32
It is important to note that IS elements such as ISAba1
can contribute to the spread of carbapenemase genes among
different Acinetobacter species. Poirel et al. (2008) hypoth-
esized that blaOXA-23 was likely mobilized by the ISAba1
insertion sequence from A. radioresistens to A. baumannii.33 The
authors demonstrated that A. radioresistens is the progenitor
of the blaOXA-23-like gene, which was mobilized to A. baumannii
through ISAba1 insertions sequence provided by A. bauman-
nii. This hypothesis is based on the identiﬁcation of genes
encoding both OXA-23-like and ATPase-like enzymes on the A.
radioresistens chromosome without the presence of ISAba1 ele-
ments, that is involved in the mobilization of blaOXA-23 gene.33
The ISAba1 element belongs to the IS4 family and has 11-
bp inverted repeats sequences ﬂanked by 9-bp direct repeats
of the target sequence. Although this element is considered
exclusive to A. baumannii,  Segal et al. (2005) identiﬁed ISAba1 in
Acinetobacter lwofﬁi isolates, demonstrating the high mobility
of these elements and indicating that transposition events of
the ISAba1 occur frequently.34 b i o l o g y 4 7 (2 0 1 6) 785–792
ISAba1 has been found upstream the blaOXA-23-like,
blaOXA-51-like, blaOXA-58-like and blaAmpC genes in A. bauman-
nii.  This IS acts as a promoter sequence which increases
the expression of resistance genes. In fact, it was demon-
strated that it is necessary the presence of ISAba1 upstream
blaOXA-23 and blaOXA-51 for these genes to confer resistance
to carbapenems.35 Although several authors have demon-
strated the relationship between ISAba1 upstream blaOXA-51
and carbapenem resistance, this may not be enough to confer
resistance, as A. baumannii isolates susceptible to carbapen-
ems with the association ISAba1/blaOXA-51 have already been
described.36
The ISAba2, ISAba3 and ISAba4 elements have also been
identiﬁed upstream blaOXA-58-like and blaOXA-23-like genes in A.
baumannii isolates.37 Giannouli et al. (2009) analyzed the inser-
tion sequences of 24 A. baumannii isolates with blaOXA-58 gene
and identiﬁed the presence ISAba2, IS18 or ISAba1 located at
the 5′ end, while at 3′ end all isolates presented the ISAba3
element. Of note, the IS elements at 5′ end of blaOXA-58 were
evidenced in strains of distinct PFGE proﬁles and ST groups in
the same geographical area. It suggests that these elements
might have been acquired through horizontal gene transfer
and conﬁrms their dissemination capacity among A. bauman-
nii isolates.38
Corvec et al. (2007) described the ﬁrst A. baumannii iso-
late harboring an ISAba4 element upstream blaOXA-23 gene, in
France. Subsequently, it was shown that an isolate from Bel-
gium containing the association of ISAba4 and the blaOXA-23
presented the same PFGE proﬁle as the isolate from France.
These ﬁndings demonstrate the propensity of resistant strains
to spread, highlighting the importance of epidemiological sur-
veys to estimate the true prevalence of isolates harboring
ISAba4/blaOXA-23.39,40
Lee et al. (2011) identiﬁed a novel 1203 bp insertion
sequence, named ISAba10.  This element was found to be
inserted into the ISAba1 element upstream blaOXA-23 gene in
an A. baumannii presenting high minimum inhibitory con-
centrations (MICs) to carbapenems (≥32 g/mL). In addition,
isolates without the insertion of this element showed MICs
between 8 and 16 g/mL. The authors suggested that this
sequence may increase 2–5-fold the blaOXA-23 gene expression.
Based on these results, they suggested that the ISAba10 ele-
ment may play an important role in carbapenem resistance
by providing an additional promoter sequence to the blaOXA-23
gene.41
IS elements have also been associated to metallo--
lactamases such as blaNDM, which have been increasingly
reported in Acinetobacter baumannii and in other Acinetobac-
ter species such as A. johnsonnii,  A. pittii, A. junii and A.
lwofﬁi.16,42–44 The blaNDM can be located either on the plas-
mid  or chromosome in Acinetobacter species.44 However, it was
evidenced that the spread of the blaNDM gene was not associ-
ated with clonal dissemination, but horizontal spread of the
genetic structure.42
Several studies reported that blaNDM gene is located
between two copies of the ISAba125 element, forming a com-
posite transposon named Tn125.  ISAba125 element provides
the -35 sequence of the hybrid promoter responsible for the
expression of the blaNDM gene.45 Curiously, this IS element
has been originally identiﬁed from an A. baumannii isolate
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ithout any association with the blaNDM gene. By contrast, this
S has been identiﬁed in Enterobacteriaceae and P. aeruginosa as
 remnant of the Tn125 and has never been identiﬁed alone
n these species. This observation suggests that A. baumannii
s a likely reservoir of ISAba125. Findings like these highlight
hat even though A. baumannii is usually recognized as a ﬁnal
cceptor for resistance genes, it may acquire several resistance
eterminants and then transfer them to Enterobacteriaceae and
seudomonas spp.
Recently, a study demonstrated that Tn125 has been dis-
upted by IS26 in A. baumannii NDM-producing isolates from
ndia. This new rearrangement has resulted in blaNDM-1 being
ithin an IS26 composite transposon, which might poten-
ially mobilize blaNDM-1 and contribute to the spread of the
arbapenemase gene.46
Robledo et al. (2010) described the ﬁrst report of blaKPC
ene in A. baumannii isolates from Puerto Rico. In that study,
our variants of blaKPC were identiﬁed: KPC-2, -3, and -4 and
 novel variant, KPC-10. The integration of these genes in
he A. baumannii chromosome was related to a transposition
vent mediated by the transposase of ISEcp1.31,47 This element
s likely to be responsible for mobilizing numerous blaCTX-M
enes and several other resistance genes such as qnrB19, rmtC,
laACC-1 and blaCMY-2g7,16,21.48 In addition, it was responsible
or the mobilization of blaCTX-M-5 from a narrow range plas-
id  to the chromosome of A. baumannii,  event similar to what
artinez et al. observed with blaKPC gene.47
As described above, ISs can cause insertion mutations,
enome rearrangements and enhance the spread of resis-
ance and virulence determinants within pathogenic species.
esides being involved in the expression and spread of
arbapenemases, IS elements such as ISAba1, ISAba10 and
SAba825 are involved on the disruption of carO gene, which
odes for an important outer membrane channel. The absence
f this outer membrane protein has been correlated with
educed susceptibility to carbapenems.41,49,50
ransposons
ransposons sequences may vary in size from 3 to 40 kb, in
ome cases containing dozens of genes. These elements are
nto two main classes: composite transposons or complex
ransposons. Composite transposons have resistance genes in
ts central region; furthermore, these elements are ﬂanked by
n insertion sequence (IS) at each end. Complex transposons
ave a more  complicated genetic structure than IS elements
r composite transposons. The classic complex transposon is
n3, which is derived from resistance plasmid R1.51
In A. baumannii,  transposons have been characterized as
enetic structures harboring important resistant genes, such
s blaOXA-23. Three transposons have been related to blaOXA-23:
n2006, Tn2007 and Tn2008. In Tn2006, the blaOXA-23 gene is
anked by two copies of the insertion sequence ISAba1, which
s located in opposite directions. Tn2008 is similar to Tn2006
ut lacks the second copy of ISAba1.  Finally, in Tn2007 the
laOXA-23 gene is associated with one copy of ISAba4 located
pstream to this gene.52 Several studies have demonstrated
hat Tn2006 is currently the most common determinant ofo l o g y 4 7 (2 0 1 6) 785–792 789
carbapenem resistance, with a great ability to spread among
A. baumannii isolates.53
Integrons
These elements are natural cloning and expression systems
that incorporate ORFs by site-speciﬁc recombination and con-
vert them to functional genes due to the presence of a
promoter sequence (Rowe-Magnus et al., 2001). It is now well
established that these mobile elements constitute the major
vectors of antibiotic multiresistance in Gram-negative and, to
a lesser extent, in Gram-positive bacteria.54
Five different classes of mobile integrons have been
deﬁned to date, based on the sequence of the encoded
integrases.54,55 It is known that three (classes 1, 2 and 3) of
these classes have an important role in the dissemination
of antimicrobial resistance genes.55,56 These classes are well
described in the literature and are associated to multiresistant
phenotypes.54,55
Several studies have demonstrated a high prevalence of
class 1 integrons in A. baumannii isolates in Europe, Asia and
United States.57 Due to its greater spread capacity, class 1 inte-
grons are the main experimental model of integrons. This
class is usually associated to functional or non functional
transposons derived from Tn402 which may be inserted into
larger transposons as Tn21.  Class 1 integrons have been asso-
ciated to a variety of insertion sequences, including IS26,
IS1999,  IS2000 e IS6100.58
Most acquired MBL genes in A. baumannii have been found
within class 1 integrons, often containing an array of resis-
tance gene cassettes.1,6 Mendes et al. (2007) described seven
blaIMP-1 harboring Acinetobacter spp. isolates recovered from
Brazilian inpatients. All isolates possessed a class 1 integ-
ron, named In86, carrying the same cassette array: blaIMP,
aac(6′)-31, and aadA1,  which was plasmid-located in ﬁve of
the isolates (Mendes et al., 2007). This gene cassette contained
a aminoglycoside resistance gene – aac(6′)-31 – that might
be capable of conferring resistance to all clinically available
aminoglycosides. This gene was able to disseminate among
unrelated A. baumannii clinical isolates from a Brazilian hos-
pital (Mendes et al., 2007). Recently, Cayô et al., reported a new
structure of class 1 integron, In990, harboring the blaIMP-10 in
A. baumannii isolates from Brazil.  The cassette arrangement
of In990 was very similar to that of In86 described by Mendes
et al.59,60
Class 2 integrons are included in the Tn7 family of
transposons, and consist of an integrase gene followed by
gene cassettes. Tn7 are identiﬁed as a sophisticated mobile
genetic element containing a transposition module formed
by ﬁve transposition genes, tnsA, tnsB, tnsC, tnsD, and tnsE,
rather than the one or two seen in many  other transposable
elements.56 Class 3 integrons are less prevalent than class 2
and are also located in transposons.54
Despite reports of a higher prevalence of class 1 integrons in
A. baumannii, studies conducted in Latin American countries
such as Chile, Argentina and Brazil demonstrated a greater
distribution of class 2 integrons among isolates of A. bauman-
nii in these regions.36,61 Fonseca et al. (2011) demonstrated
that all class 2 integrons obtained from Brazilian isolates
 i c r o
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were inserted into Tn7 transposon, besides having the gene
cassette containing the arrangement of genes dfrA1 (trimetho-
prim resistance), sat2 (streptothricin resistance) and aadA1
(spectinomycin and streptomycin resistance).62
Martins et al. (2015) investigated the association of class
2 integrons and gene cassettes with clonal lineages of A. bau-
mannii. They reported the association of class 1 and 2 integrons
with CC109/1 (International Clone I) and CC113/79 A. bauman-
nii strains, respectively. The authors hypothesized that class 2
integron, predominant in Latin America, may be accounted for
the high prevalence of the CC113/79 type. In the same study,
a similar prevalence was observed for A. nosocomialis.63
Class 1 and 2 integrons have been described in A. baumannii
isolates related to nosocomial infection outbreaks. In a study
published by Turton et al. (2005), it was observed that all A.
baumannii isolates associated with outbreaks contained class
1 integrons, in contrast, none sporadic isolate presented this
class of integron.64
More  than 130 different gene cassettes containing resis-
tance genes have been identiﬁed in integrons. Distinct genes
are evidenced in gene cassettes, promoting resistance to a
variety of antimicrobial classes. Together, these gene cassettes
provide resistance to most classes of antibiotics including
-lactams, all aminoglycosides, chloramphenicol, trimetho-
prim, streptothricin, rifampin, erythromycin, fosfomycin,
lincomycin, quinolones, and antiseptics of the quaternary
ammonium-compound family.65 Besides these genes, several
ORFs with unknown function have been identiﬁed in gene
cassettes.66
In A. baumannii,  gene cassettes have been described con-
taining several genes, such as aacA4 responsible for resistance
to amikacin, netilmicin and tobramycin, the catB8 gene is an
acetyltransferase which encodes resistance to chlorampheni-
col, aadA1 is responsible for resistance to streptomycin and
spectinomycin, aac3 responsible for resistance to gentamicin
and blaOXA-10 encodes resistance to -lactams, except car-
bapenems and extended-spectrum cephalosporins.21
Final  remarks
This review highlighted the role of resistance determinants
in the capacity of spread in A. baumannii.  This species shows
a considerable ability to acquire foreign DNA such as drug
resistance genes, which provide a genetic diversity and over-
comes the antibiotic selection pressure. It is important to note
that the main carbapenem-resistance mechanism involved
in A. baumannii (production of oxacillinases) presents a low
hydrolytic power when it is not associated with an insertion
sequence. Moreover, the capacity of OXA genes to spread is
directly related to their association with a composite trans-
poson (Tn2006). These features highlight the importance of
investigating the genetic context of these genes in order to
deﬁne their real clinical signiﬁcance.
The continuous description of gene cassettes in integrons,
mainly those leading to resistance to -lactams and aminogly-
cosides, has been of great concern. Furthermore, the number
of resistance genes inserted in the same plasmid, even in the
same integron, seems to be increasing. This integration of
resistance determinants in the same plasmid may facilitate b i o l o g y 4 7 (2 0 1 6) 785–792
the persistence in the environment for long periods because
of the physical association of integrons with other elements,
allowing their continued selection.57
In this context, the knowledge about the genetic struc-
ture of resistance determinants is very important in order to
understand the capacity of resistance genes to spread in A.
baumannii.
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